These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30825431)

  • 1. Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis.
    García-Martín A; Garrido-Rodríguez M; Navarrete C; Caprioglio D; Palomares B; DeMesa J; Rollland A; Appendino G; Muñoz E
    Biochem Pharmacol; 2019 May; 163():321-334. PubMed ID: 30825431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB
    Del Rio C; Cantarero I; Palomares B; Gómez-Cañas M; Fernández-Ruiz J; Pavicic C; García-Martín A; Luz Bellido M; Ortega-Castro R; Pérez-Sánchez C; López-Pedrera C; Appendino G; Calzado MA; Muñoz E
    Br J Pharmacol; 2018 Oct; 175(19):3813-3831. PubMed ID: 30033591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.
    García-Martín A; Garrido-Rodríguez M; Navarrete C; Del Río C; Bellido ML; Appendino G; Calzado MA; Muñoz E
    Biochem Pharmacol; 2018 Nov; 157():304-313. PubMed ID: 30076848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
    del Río C; Navarrete C; Collado JA; Bellido ML; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Pollastro F; Appendino G; Calzado MA; Cantarero I; Muñoz E
    Sci Rep; 2016 Feb; 6():21703. PubMed ID: 26887982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.
    Gonzalez EG; Selvi E; Balistreri E; Akhmetshina A; Palumbo K; Lorenzini S; Lazzerini PE; Montilli C; Capecchi PL; Lucattelli M; Baldi C; Gianchecchi E; Galeazzi M; Pasini FL; Distler JH
    Ann Rheum Dis; 2012 Sep; 71(9):1545-51. PubMed ID: 22492781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling.
    Tian N; Cheng H; Du Y; Wang X; Lei Y; Liu X; Chen M; Xu Z; Wang L; Yin H; Fu R; Li D; Zhou P; Lu L; Yin Z; Dai SM; Li B
    J Autoimmun; 2024 Jul; 147():103233. PubMed ID: 38797049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
    Servettaz A; Kavian N; Nicco C; Deveaux V; Chéreau C; Wang A; Zimmer A; Lotersztajn S; Weill B; Batteux F
    Am J Pathol; 2010 Jul; 177(1):187-96. PubMed ID: 20508030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice.
    García-Martín A; Navarrete C; Garrido-Rodríguez M; Prados ME; Caprioglio D; Appendino G; Muñoz E
    Biomed Pharmacother; 2021 Oct; 142():112007. PubMed ID: 34385107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis.
    Jiang X; Chen S; Zhang Q; Yi C; He J; Ye X; Liu M; Lu W
    Phytomedicine; 2020 Feb; 67():153160. PubMed ID: 31901889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
    Ruzehaji N; Frantz C; Ponsoye M; Avouac J; Pezet S; Guilbert T; Luccarini JM; Broqua P; Junien JL; Allanore Y
    Ann Rheum Dis; 2016 Dec; 75(12):2175-2183. PubMed ID: 26961294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
    Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
    Luo H; Zhu H; Zhou B; Xiao X; Zuo X
    Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
    J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of kaempferol on skin fibrosis in systemic sclerosis by the suppression of oxidative stress.
    Sekiguchi A; Motegi SI; Fujiwara C; Yamazaki S; Inoue Y; Uchiyama A; Akai R; Iwawaki T; Ishikawa O
    J Dermatol Sci; 2019 Oct; 96(1):8-17. PubMed ID: 31447184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.